Assignee
ALFACELL CORP
US·20 granted patents·8 pending applications·237 citations·filing 1988–2010
Top patents by PatentIndex Score
28 records- 0192US7585654B2Nucleic acid encoding cysteinized ribonuclease to which a targeting moiety can be conjugatedALFACELL CORP·Filed 2008·Granted Sep 8, 2009·7 cites·3 claims
- 0291US7229824B2Ribonucleases and methods of making them recombinantlyALFACELL CORP·Filed 2003·Granted Jun 12, 2007·11 cites·3 claims
- 0389US7763449B2Nucleic acid encoding a novel ribonuclease having an amino acid sequence made up of the amino acid sequence of a known ribonuclease and an N-terminal leader sequence that is at least one residue longALFACELL CORP·Filed 2008·Granted Jul 27, 2010·4 cites·2 claims
- 0489US7556952B2Nucleic acid encoding a novel ribonuclease having an amino acid sequence made up of a known amino acid sequence and an initial N-terminal residueALFACELL CORP·Filed 2008·Granted Jul 7, 2009·4 cites·1 claims
- 0589US7556951B2Nucleic acid encoding a novel ribonuclease having an amino acid sequence made up of the amino acid sequence of a known ribonuclease and an n-terminal leader sequence that is at least one residue longALFACELL CORP·Filed 2008·Granted Jul 7, 2009·4 cites·2 claims
- 0689US7473542B2Cysteinized ribonuclease and targeting moiety conjugated theretoALFACELL CORP·Filed 2007·Granted Jan 6, 2009·4 cites·1 claims
- 0789US7442535B2Fusion protein incorporating a cysteinized ribonucleaseALFACELL CORP·Filed 2007·Granted Oct 28, 2008·4 cites·1 claims
- 0889US7442536B2Cysteinized ribonuclease and targeting moiety conjugated theretoALFACELL CORP·Filed 2007·Granted Oct 28, 2008·4 cites·3 claims
- 0987US7585655B2Nucleic acid encoding a fusion protein incorporating a cysteinized ribonucleaseALFACELL CORP·Filed 2008·Granted Sep 8, 2009·4 cites·2 claims
- 1087US7556953B2Nucleic acid encoding a novel ribonuclease having an amino acid sequence made up of the amino acid sequence of a known ribonuclease and an N-terminal leader sequenceALFACELL CORP·Filed 2008·Granted Jul 7, 2009·4 cites·2 claims
- 1179US6239257B1Family of proteins belonging to the pancreatic ribonuclease a superfamilyALFACELL CORP·Filed 1998·Granted May 29, 2001·50 cites·10 claims
- 1278US5559212AFrog embryo and egg-derived tumor cell anti-proliferation proteinALFACELL CORP·Filed 1994·Granted Sep 24, 1996·52 cites·1 claims
- 1377US6423515B1Methods of making nucleic acids encoding ribonucleasesALFACELL CORP·Filed 2000·Granted Jul 23, 2002·4 cites·7 claims
- 1471US6175003B1Nucleic acids encoding ribonucleases and methods of making themALFACELL CORP·Filed 1999·Granted Jan 16, 2001·23 cites·8 claims
- 1568US2007231891A1Ribonucleases and methods of making them recombinantlyALFACELL CORP·Filed 2007·Application pending·0 cites
- 1668US2007238861A1Ribonucleases and methods of making them recombinantlyALFACELL CORP·Filed 2007·Application pending·0 cites
- 1768US2007231890A1Ribonucleases and methods of making them recombinantlyALFACELL CORP·Filed 2007·Application pending·0 cites
- 1866US2007232543A1Ribonucleases and methods of making them recombinantlyALFACELL CORP·Filed 2007·Application pending·0 cites
- 1963US2010317082A1Related ribonucleases in which an amino acid sequence of a known ribonuclease is preceded by at least one residue at the n-terminus, and methods of making them recombinantlyALFACELL CORP·Filed 2010·Application pending·0 cites
- 2062US2010291657A1Ribonucleases in which an amino acid sequence of a known ribonuclease is preceded by at least one residue at the n-terminus, and methods of making them recombinantlyALFACELL CORP·Filed 2010·Application pending·0 cites
- 2162US2010304463A1Ribonuclease in which an amino acid sequence of a known ribonuclease is preceded by a residue at the n-terminus, and a method of making it recombinantlyALFACELL CORP·Filed 2010·Application pending·0 cites
- 2257US5728805APharmaceuticals and method for making themALFACELL CORP·Filed 1995·Granted Mar 17, 1998·18 cites·5 claims
- 2349US2004126865A1Nucleic acids encoding ranpirnase variants and methods of making themALFACELL CORP·Filed 2002·Application pending·0 cites
- 2448US6290951B1Alteration of the cell cycle in vivo, and particularly for inducing apoptosis of tumor cellsALFACELL CORP·Filed 1998·Granted Sep 18, 2001·9 cites·28 claims
- 2544US4882421APharmaceutical for treating tumors and method for making itALFACELL CORP·Filed 1988·Granted Nov 21, 1989·15 cites·21 claims
- 2643US5529775ACompositions comprising ONCONASE(™) and cisplatin, melphalan, or doxorubicin HClALFACELL CORP·Filed 1994·Granted Jun 25, 1996·6 cites·3 claims
- 2740US5595734ACompositions comprising ONCONASE (tm) and lovastatinALFACELL CORP·Filed 1992·Granted Jan 21, 1997·5 cites·1 claims
- 2836US5540925ACompositions comprising ONCONASE (TM) and STELAZINE (TM) or TAMOXIFEN (TM)ALFACELL CORP·Filed 1994·Granted Jul 30, 1996·5 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when ALFACELL CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →